Close Menu

23andMe

The move raises questions about what precisely is an LDT outside of FDA jurisdiction and heightens concerns that poorly validated tests will enter the market and endanger public health.

The firm can now tell customers if their genotypes may impact their response to clopidogrel and citalopram without the need for confirmatory testing.

The next iteration of Ancestry's Health experience seeks to provide customers with actionable information about certain commonly inherited health conditions.

Using historical records and genetic data from consented 23andMe customers and others, researchers provided new insights about slavery in the Americas.

In the study, called Coronagenes, the team aims to identify genes that influence the risk of developing COVID-19 and affect disease severity.

Stat News offers ways consumer genetic testing companies could address racial disparities.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

Data collected from volunteers will be used in a genome-wide association study to better understand COVID-19.

The Helsinki-based firm is making its panel available for free to people who already have been genotyped by consumer genomics services or biobanks.

Drawing from its massive consumer genetic dataset and longitudinal survey data, 23andMe is searching for genetic features that might influence the severity of SARS-CoV-2 infections.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.